• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331

Introduction to 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide (CAS No. 880613-19-4)

4-Chloro-2-(methylthio)pyrimidine-5-carboxamide, identified by its Chemical Abstracts Service (CAS) number 880613-19-4, is a significant compound in the realm of pharmaceutical and agrochemical research. This heterocyclic organic molecule belongs to the pyrimidine class, a structural motif widely recognized for its biological activity and synthetic utility. The presence of a chloro substituent at the 4-position and a methylthio group at the 2-position, along with a carboxamide functional group at the 5-position, endows this compound with unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The pyrimidine scaffold is fundamental in medicinal chemistry due to its resemblance to nucleic acid bases, which are essential components of DNA and RNA. Compounds derived from pyrimidine have been extensively explored for their potential as pharmacological agents, including antiviral, anticancer, and antimicrobial applications. The specific arrangement of substituents in 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide enhances its reactivity and compatibility with diverse synthetic transformations, making it a versatile building block for drug discovery programs.

In recent years, there has been growing interest in developing novel pyrimidine-based inhibitors targeting key enzymes and receptors involved in disease pathways. For instance, studies have highlighted the importance of pyrimidine derivatives in modulating enzymes such as kinases and polymerases, which are often dysregulated in cancer and viral infections. The chloro and methylthio substituents in this compound contribute to its ability to engage with biological targets through dipole-dipole interactions and hydrogen bonding, facilitating the design of high-affinity ligands.

One of the most compelling aspects of 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide is its role as a precursor in the synthesis of more complex molecules. Researchers have leveraged its structural features to develop libraries of compounds for high-throughput screening (HTS) campaigns. The carboxamide group, in particular, provides a site for further functionalization via amide coupling reactions, enabling the introduction of diverse pharmacophores. This flexibility has been exploited in the development of novel therapeutic agents with improved efficacy and reduced toxicity.

The agrochemical sector has also benefited from the versatility of 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide. Pyrimidine derivatives are well-known for their activity against various pests and pathogens, making them valuable components in crop protection formulations. The compound’s ability to undergo structural modifications allows chemists to fine-tune its properties for specific applications, such as herbicides or fungicides. Recent studies have demonstrated its potential in developing next-generation agrochemicals that offer enhanced environmental safety profiles while maintaining potent biological activity.

Advances in computational chemistry have further accelerated the exploration of 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide and its derivatives. Molecular modeling techniques enable researchers to predict binding affinities and optimize lead structures before experimental synthesis. This approach has been particularly effective in identifying novel inhibitors targeting challenging therapeutic areas such as antibiotic-resistant bacteria and oncogenic viruses. The integration of machine learning algorithms with traditional pharmacophore modeling has enhanced the efficiency of drug discovery pipelines, reducing both time-to-market and development costs.

The synthesis of 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide itself presents an interesting challenge due to the need for precise regioselectivity during functionalization. Modern synthetic methodologies, including transition-metal-catalyzed cross-coupling reactions and flow chemistry techniques, have enabled more efficient and scalable production processes. These advancements not only improve yield but also minimize waste generation, aligning with green chemistry principles. The compound’s synthesis often involves multi-step sequences that showcase the ingenuity of organic chemists in navigating complex reaction pathways.

From a mechanistic perspective, understanding how 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide interacts with biological targets is crucial for optimizing its therapeutic potential. Structural biology techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy have provided insights into how these compounds bind to proteins and enzymes at an atomic level. Such detailed knowledge allows medicinal chemists to rationally design analogs with improved binding properties or altered selectivity profiles.

The future prospects for 4-Chloro-2-(methylthio)pyrimidine-5-carboxamide are promising, given its broad applicability across multiple industries. As research continues to uncover new biological targets and synthetic strategies, this compound is likely to remain a cornerstone in pharmaceutical innovation. Collaborative efforts between academia and industry will be essential in translating laboratory discoveries into viable therapeutics that address unmet medical needs worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)